首页 > 最新文献

Journal of Clinical Microbiology最新文献

英文 中文
Photo Quiz: Incidental cyst lesions during COVID-19 pneumonia admission.
IF 6.1 2区 医学 Q1 MICROBIOLOGY Pub Date : 2025-02-19 DOI: 10.1128/jcm.00494-24
Alfredo Maldonado-Barrueco, Guillermo Ruiz-Carrascoso, Rosa de Miguel-Buckley, Susana Ayuela-García, Julio García-Rodríguez, Marta Mora-Rillo
{"title":"Photo Quiz: Incidental cyst lesions during COVID-19 pneumonia admission.","authors":"Alfredo Maldonado-Barrueco, Guillermo Ruiz-Carrascoso, Rosa de Miguel-Buckley, Susana Ayuela-García, Julio García-Rodríguez, Marta Mora-Rillo","doi":"10.1128/jcm.00494-24","DOIUrl":"10.1128/jcm.00494-24","url":null,"abstract":"","PeriodicalId":15511,"journal":{"name":"Journal of Clinical Microbiology","volume":"63 2","pages":"e0049424"},"PeriodicalIF":6.1,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11837528/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143449200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interlaboratory assays from the fungal PCR Initiative and the Modimucor Study Group to improve qPCR detection of Mucorales DNA in serum: one more step toward standardization. 来自真菌PCR倡议和Modimucor研究组的实验室间分析,以改进血清中Mucorales DNA的qPCR检测:朝着标准化又迈出了一步。
IF 6.1 2区 医学 Q1 MICROBIOLOGY Pub Date : 2025-02-19 Epub Date: 2024-12-31 DOI: 10.1128/jcm.01525-24
Steffi Rocchi, Emeline Scherer, P Lewis White, Audrey Guitton, Alexandre Alanio, Françoise Botterel, Marie Elisabeth Bougnoux, Maria José Buitrago, Massimo Cogliati, Marjorie Cornu, Celine Damiani, Julie Denis, Damien Dupont, Stefan Fuchs, Rebecca Gorton, Pieter-Jan Haas, Ferry Hagen, Rasmus Hare, Xavier Iriart, Corné H W Klaassen, Michaela Lackner, Martina Lengerova, Willem J G Melchers, Florent Morio, Philippe Poirier, Jan Springer, Stephane Valot, Birgit Willinger, Cristina Mazzi, Mario Cruciani, Rosemary Barnes, J Peter Donnelly, Jürgen Loeffler, Laurence Millon

The aim of this study was to identify parameters influencing DNA extraction and PCR amplification efficiencies in an attempt to standardize Mucorales qPCR. The Fungal PCR Initiative Mucorales Laboratory Working Group distributed two panels of simulated samples to 26 laboratories: Panel A (six sera spiked with Mucorales DNA and one negative control serum) and Panel B (six Mucorales DNA extracts). Panel A underwent DNA extraction in each laboratory according to the local procedure and were sent to a central laboratory for testing using three different qPCR techniques: one in-house qPCR assay and two commercial assays (MucorGenius and Fungiplex). Panel B DNA extracts were PCR amplified in each laboratory using local procedures: nine in-house qPCR assays and two commercial kits (MucorGenius and MycoGENIE). All data were compiled and anonymously analyzed at the central laboratory. For Panel A, a total of six different automated platforms and five manual extraction methods were used. Positive rates were 64%, 70%, and 89%, for the MucorGenius, Fungiplex, and the in-house qPCR assay, respectively. Using a large volume of serum for DNA extraction provided the highest analytical sensitivity (82.5% for 1 mL compared with 62.7% for smaller volumes, P < 0.01). For Panel B, five in-house qPCR assays and two commercial kits had >78% positivity. Using larger PCR input volumes (≥7 µL) was associated with the highest sensitivity at 95.5% compared to 58.3% when lower input volumes were used (P < 0.01). Using larger sample volumes for nucleic acid extraction and DNA template volumes for PCR amplification significantly improves the performance of Mucorales qPCR when testing serum.

Importance: Mucormycosis is a life-threatening mold infection affecting immunosuppressed patients but also other patients with diabetes or trauma. Better survival is linked to shorter delays in diagnosis and treatment initiation. Detection of Mucorales-free DNA in serum or plasma using quantitative PCR allows a prompt diagnosis and earlier treatment. Several techniques and protocols of quantitative Mucorales PCR are used in Europe, and improving performance remains a common objective of laboratories participating in the fungal PCR Initiative Working Group. This study, which combined results from 26 laboratories in Europe, showed that the main parameters underpinning sensitivity are the preanalytical variables (volume of serum used for DNA extraction and DNA template volume), irrespective of the extraction platforms and qPCR assay/platform.

本研究的目的是确定影响DNA提取和PCR扩增效率的参数,试图标准化Mucorales qPCR。真菌PCR倡议Mucorales实验室工作组向26个实验室分发了两组模拟样本:A组(六份含有Mucorales DNA的血清和一份阴性对照血清)和B组(六份Mucorales DNA提取物)。A组在每个实验室根据当地程序进行DNA提取,并被送到中心实验室使用三种不同的qPCR技术进行检测:一种内部qPCR检测和两种商业检测(MucorGenius和Fungiplex)。每个实验室使用本地程序对B组DNA提取物进行PCR扩增:9个内部qPCR检测和2个商业试剂盒(MucorGenius和MycoGENIE)。所有数据均在中心实验室进行匿名汇编和分析。对于A组,总共使用了6种不同的自动化平台和5种人工提取方法。MucorGenius、Fungiplex和内部qPCR检测的阳性率分别为64%、70%和89%。使用大体积的血清提取DNA具有最高的分析灵敏度(1ml为82.5%,小体积为62.7%,P < 0.01)。对于B组,5个内部qPCR检测和2个商业试剂盒的阳性率为0.78%。使用较大的PCR输入量(≥7µL)与最高的灵敏度相关,为95.5%,而使用较小的输入量时为58.3% (P < 0.01)。使用更大的样品体积进行核酸提取和DNA模板体积进行PCR扩增,显著提高了Mucorales qPCR检测血清的性能。重要性:毛霉病是一种危及生命的霉菌感染,影响免疫抑制患者,但也影响其他糖尿病或创伤患者。较好的生存率与较短的诊断和开始治疗延误有关。使用定量PCR检测血清或血浆中无粘膜菌的DNA可以及时诊断和早期治疗。欧洲使用了几种定量Mucorales PCR的技术和方案,提高性能仍然是参与真菌PCR倡议工作组的实验室的共同目标。这项研究结合了欧洲26个实验室的结果,表明支持灵敏度的主要参数是分析前变量(用于DNA提取的血清体积和DNA模板体积),而与提取平台和qPCR检测/平台无关。
{"title":"Interlaboratory assays from the fungal PCR Initiative and the Modimucor Study Group to improve qPCR detection of Mucorales DNA in serum: one more step toward standardization.","authors":"Steffi Rocchi, Emeline Scherer, P Lewis White, Audrey Guitton, Alexandre Alanio, Françoise Botterel, Marie Elisabeth Bougnoux, Maria José Buitrago, Massimo Cogliati, Marjorie Cornu, Celine Damiani, Julie Denis, Damien Dupont, Stefan Fuchs, Rebecca Gorton, Pieter-Jan Haas, Ferry Hagen, Rasmus Hare, Xavier Iriart, Corné H W Klaassen, Michaela Lackner, Martina Lengerova, Willem J G Melchers, Florent Morio, Philippe Poirier, Jan Springer, Stephane Valot, Birgit Willinger, Cristina Mazzi, Mario Cruciani, Rosemary Barnes, J Peter Donnelly, Jürgen Loeffler, Laurence Millon","doi":"10.1128/jcm.01525-24","DOIUrl":"10.1128/jcm.01525-24","url":null,"abstract":"<p><p>The aim of this study was to identify parameters influencing DNA extraction and PCR amplification efficiencies in an attempt to standardize Mucorales qPCR. The Fungal PCR Initiative Mucorales Laboratory Working Group distributed two panels of simulated samples to 26 laboratories: Panel A (six sera spiked with Mucorales DNA and one negative control serum) and Panel B (six Mucorales DNA extracts). Panel A underwent DNA extraction in each laboratory according to the local procedure and were sent to a central laboratory for testing using three different qPCR techniques: one in-house qPCR assay and two commercial assays (MucorGenius and Fungiplex). Panel B DNA extracts were PCR amplified in each laboratory using local procedures: nine in-house qPCR assays and two commercial kits (MucorGenius and MycoGENIE). All data were compiled and anonymously analyzed at the central laboratory. For Panel A, a total of six different automated platforms and five manual extraction methods were used. Positive rates were 64%, 70%, and 89%, for the MucorGenius, Fungiplex, and the in-house qPCR assay, respectively. Using a large volume of serum for DNA extraction provided the highest analytical sensitivity (82.5% for 1 mL compared with 62.7% for smaller volumes, <i>P</i> < 0.01). For Panel B, five in-house qPCR assays and two commercial kits had >78% positivity. Using larger PCR input volumes (≥7 µL) was associated with the highest sensitivity at 95.5% compared to 58.3% when lower input volumes were used (<i>P</i> < 0.01). Using larger sample volumes for nucleic acid extraction and DNA template volumes for PCR amplification significantly improves the performance of Mucorales qPCR when testing serum.</p><p><strong>Importance: </strong>Mucormycosis is a life-threatening mold infection affecting immunosuppressed patients but also other patients with diabetes or trauma. Better survival is linked to shorter delays in diagnosis and treatment initiation. Detection of Mucorales-free DNA in serum or plasma using quantitative PCR allows a prompt diagnosis and earlier treatment. Several techniques and protocols of quantitative Mucorales PCR are used in Europe, and improving performance remains a common objective of laboratories participating in the fungal PCR Initiative Working Group. This study, which combined results from 26 laboratories in Europe, showed that the main parameters underpinning sensitivity are the preanalytical variables (volume of serum used for DNA extraction and DNA template volume), irrespective of the extraction platforms and qPCR assay/platform.</p>","PeriodicalId":15511,"journal":{"name":"Journal of Clinical Microbiology","volume":" ","pages":"e0152524"},"PeriodicalIF":6.1,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11837492/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of two MALDI-TOF MS systems and extraction methods for identification of filamentous fungi recovered from clinical specimens. 两种MALDI-TOF质谱系统及提取方法对临床标本中丝状真菌鉴定的评价。
IF 6.1 2区 医学 Q1 MICROBIOLOGY Pub Date : 2025-02-19 Epub Date: 2025-01-14 DOI: 10.1128/jcm.01548-24
Eric M Ransom, Meghan A Wallace, Nathan P Wiederhold, Connie Cañete-Gibas, Carey-Ann D Burnham

Rapid and accurate identification of cultured molds is important to determine clinical significance and therapeutic decision-making. Conventional mold identification uses phenotypic macroscopic and microscopic characterization; however, this can take days or weeks for colony maturity and definitive microscopic structure formation, be limited to genus-level identification, and be misidentified due to morphologic mimics or similarities between closely related species. Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) revolutionized bacterial and yeast identification but remains uncommon for molds in part because of limited reference libraries. Here, a retrospective 5-year review at a large teaching hospital found that 88.6% of identified molds were in the Bruker Filamentous Fungi Library 3.0 and 91.5% in the VITEK Knowledge Base Library 3.2.0. A prospective evaluation was also performed on early growth from 205 consecutive, working clinical isolates. Each mold was processed using the VITEK chemical extraction method and modified NIH chemical plus bead-beating extraction method; both extractions were tested on both systems. When compared to conventional identification, more molds were identified using VITEK extractions over NIH extractions using the VITEK (65 and 59%) and Bruker (56 and 54%) systems, respectively, using the ≥1.5 log Bruker threshold. VITEK MS identified more molds, regardless of the extraction method. Isolates without consensus agreement (n = 116) underwent sequence-based identification, which demonstrated that conventional identification had the highest genus-level (84%) but lowest species-level (3%) identification rates compared to VITEK (59 and 52%, respectively) and Bruker (52 and 36%) using VITEK extractions. Taken together, our findings suggest both MALDI-TOF systems can supplement conventional mold identification to optimize identification rates with species-level distinction.

Importance: Mold identification using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) remains uncommon in clinical laboratories. Contributing concerns include limited genus/species spectra in the MALDI-TOF MS libraries, varying success rates in the literature regarding extraction methods and instrumentation, and the lack of practical performance evaluations using early mold colony growth, which would be used in a clinical mycology laboratory. This study used multiple approaches to improve our understanding of the clinical utility and performance of MALDI-TOF MS mold identification.

快速准确地鉴定培养霉菌对确定临床意义和治疗决策具有重要意义。传统的霉菌鉴定采用表型宏观和微观表征;然而,这可能需要数天或数周的时间来使菌落成熟和确定的微观结构形成,仅限于属水平的鉴定,并且由于形态模仿或密切相关物种之间的相似性而被错误鉴定。基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)彻底改变了细菌和酵母的鉴定,但由于参考文库有限,在霉菌鉴定中仍然不常见。本文对某大型教学医院5年的回顾性研究发现,88.6%的已鉴定霉菌存在于Bruker丝状真菌库3.0中,91.5%存在于VITEK知识库库3.2.0中。对205个连续临床分离株的早期生长进行了前瞻性评估。每个模具采用VITEK化学萃取法和改良的NIH化学加打珠萃取法进行加工;两种萃取物都在两种系统上进行了测试。与传统鉴定相比,使用VITEK提取液比使用VITEK(65%和59%)和Bruker(56%和54%)系统的NIH提取液鉴定出更多的霉菌,使用≥1.5 log Bruker阈值。无论提取方法如何,VITEK MS鉴定出更多的霉菌。未达成一致协议的分离株(n = 116)进行了基于序列的鉴定,结果表明,与使用VITEK提取液(分别为59%和52%)和Bruker提取液(分别为52%和36%)相比,常规鉴定具有最高的属水平(84%)和最低的种水平(3%)鉴定率。综上所述,我们的研究结果表明,MALDI-TOF系统可以补充传统的霉菌鉴定,以优化物种水平区分的鉴定率。重要性:使用基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)进行霉菌鉴定在临床实验室中仍然不常见。主要问题包括MALDI-TOF MS文库中有限的属/种光谱,关于提取方法和仪器的文献成功率不同,以及缺乏临床真菌学实验室中使用的早期霉菌菌落生长的实际性能评估。本研究使用了多种方法来提高我们对MALDI-TOF质谱霉菌鉴定的临床应用和性能的理解。
{"title":"Evaluation of two MALDI-TOF MS systems and extraction methods for identification of filamentous fungi recovered from clinical specimens.","authors":"Eric M Ransom, Meghan A Wallace, Nathan P Wiederhold, Connie Cañete-Gibas, Carey-Ann D Burnham","doi":"10.1128/jcm.01548-24","DOIUrl":"10.1128/jcm.01548-24","url":null,"abstract":"<p><p>Rapid and accurate identification of cultured molds is important to determine clinical significance and therapeutic decision-making. Conventional mold identification uses phenotypic macroscopic and microscopic characterization; however, this can take days or weeks for colony maturity and definitive microscopic structure formation, be limited to genus-level identification, and be misidentified due to morphologic mimics or similarities between closely related species. Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) revolutionized bacterial and yeast identification but remains uncommon for molds in part because of limited reference libraries. Here, a retrospective 5-year review at a large teaching hospital found that 88.6% of identified molds were in the Bruker Filamentous Fungi Library 3.0 and 91.5% in the VITEK Knowledge Base Library 3.2.0. A prospective evaluation was also performed on early growth from 205 consecutive, working clinical isolates. Each mold was processed using the VITEK chemical extraction method and modified NIH chemical plus bead-beating extraction method; both extractions were tested on both systems. When compared to conventional identification, more molds were identified using VITEK extractions over NIH extractions using the VITEK (65 and 59%) and Bruker (56 and 54%) systems, respectively, using the ≥1.5 log Bruker threshold. VITEK MS identified more molds, regardless of the extraction method. Isolates without consensus agreement (<i>n</i> = 116) underwent sequence-based identification, which demonstrated that conventional identification had the highest genus-level (84%) but lowest species-level (3%) identification rates compared to VITEK (59 and 52%, respectively) and Bruker (52 and 36%) using VITEK extractions. Taken together, our findings suggest both MALDI-TOF systems can supplement conventional mold identification to optimize identification rates with species-level distinction.</p><p><strong>Importance: </strong>Mold identification using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) remains uncommon in clinical laboratories. Contributing concerns include limited genus/species spectra in the MALDI-TOF MS libraries, varying success rates in the literature regarding extraction methods and instrumentation, and the lack of practical performance evaluations using early mold colony growth, which would be used in a clinical mycology laboratory. This study used multiple approaches to improve our understanding of the clinical utility and performance of MALDI-TOF MS mold identification.</p>","PeriodicalId":15511,"journal":{"name":"Journal of Clinical Microbiology","volume":" ","pages":"e0154824"},"PeriodicalIF":6.1,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11837564/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142978406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anidulafungin is a useful surrogate marker for predicting in vitro susceptibility to rezafungin among five Candida species using CLSI methods and interpretive criteria. Anidulafungin是利用CLSI方法和解释标准预测五种念珠菌对rezafungin体外敏感性的有用替代标记物。
IF 6.1 2区 医学 Q1 MICROBIOLOGY Pub Date : 2025-02-19 Epub Date: 2025-01-22 DOI: 10.1128/jcm.01129-24
Marisa L Winkler, Lalitagauri Deshpande, John H Kimbrough, Maura Karr, Paul Rhomberg, Abby L Klauer, Mariana Castanheira

This study addresses the use of other echinocandins as surrogate markers to predict the susceptibility of rezafungin against the six most common Candida spp. The Clinical Laboratory Standards Institute (CLSI) reference broth microdilution method was performed to test 5,720 clinical isolates of six different Candida species. Species-specific interpretative criteria by CLSI breakpoints or epidemiological cutoff values were applied. Essential agreement was 100% within two doubling dilutions for all species and comparisons. The categorical agreement of rezafungin using anidulafungin against all Candida spp. was 97.6% (2.9% very major errors [VMEs], 0.2% major errors [MEs], and 2.2% minor errors [miEs]); for caspofungin, it was 99.6% (11.4% VME, 0.09% ME, and 0.19% miE); and for micafungin, it was 99.6% (14.3% VME, 0.15% ME, and 0.17% miE). There were species-specific differences that led to unacceptably high VME for Candida dubliniensis with all agents and for Candida parapsilosis when caspofungin or micafungin but not anidulafungin was used as the comparator. Genetic analysis showed rezafungin nonsusceptibility correlated well with FKS hotspot mutations. The best-performing surrogate was anidulafungin, which can be used to predict rezafungin susceptible or nonsusceptible in Candida albicans, Candida glabrata, Candida parapsilosis, Candida tropicalis, and Candida krusei with low error rates and ≥90% essential and categorical agreement. Micafungin or caspofungin can also be used as a surrogate marker for predicting rezafungin susceptible or nonsusceptible in C. albicans, C. glabrata, C. tropicalis, and C. krusei. No surrogate performs appropriately to determine rezafungin susceptibility for C. dubliniensis.

本研究采用临床实验室标准协会(CLSI)标准肉汤微量稀释法对5720株临床分离的6种不同念珠菌进行了检测,探讨了用其他棘珠菌素作为替代标记物来预测rezafungin对6种常见念珠菌的敏感性。采用CLSI断点或流行病学截止值的物种特异性解释标准。在两次加倍稀释中,所有物种和比较的基本一致性为100%。rezafungin使用anidulafungin治疗所有念珠菌属的分类一致性为97.6%(非常严重错误2.9%,严重错误0.2%,轻微错误2.2%);caspofungin为99.6% (VME 11.4%, ME 0.09%, miE 0.19%);micafungin为99.6% (14.3% VME, 0.15% ME, 0.17% miE)。当使用卡泊芬宁或米卡芬宁而不是阿尼杜拉芬宁作为比较剂时,所有药物对dubliniensis的VME都存在物种特异性差异,导致不可接受的高VME。遗传分析表明,rezafungin不易感性与FKS热点突变相关。效果最好的替代物是anidulafungin,可用于预测白色念珠菌、光秃念珠菌、假丝酵母菌、热带念珠菌和克鲁氏念珠菌的rezafungin敏感或不敏感,错误率低,基本和分类一致性≥90%。Micafungin或caspofungin也可以作为预测白色念珠菌、光滑念珠菌、热带念珠菌和克鲁塞念珠菌对rezafungin敏感或不敏感的替代标记物。没有合适的替代物可以确定dubliniensis对rezafungin的敏感性。
{"title":"Anidulafungin is a useful surrogate marker for predicting <i>in vitro</i> susceptibility to rezafungin among five <i>Candida</i> species using CLSI methods and interpretive criteria.","authors":"Marisa L Winkler, Lalitagauri Deshpande, John H Kimbrough, Maura Karr, Paul Rhomberg, Abby L Klauer, Mariana Castanheira","doi":"10.1128/jcm.01129-24","DOIUrl":"10.1128/jcm.01129-24","url":null,"abstract":"<p><p>This study addresses the use of other echinocandins as surrogate markers to predict the susceptibility of rezafungin against the six most common <i>Candida</i> spp. The Clinical Laboratory Standards Institute (CLSI) reference broth microdilution method was performed to test 5,720 clinical isolates of six different <i>Candida</i> species. Species-specific interpretative criteria by CLSI breakpoints or epidemiological cutoff values were applied. Essential agreement was 100% within two doubling dilutions for all species and comparisons. The categorical agreement of rezafungin using anidulafungin against all <i>Candida</i> spp. was 97.6% (2.9% very major errors [VMEs], 0.2% major errors [MEs], and 2.2% minor errors [miEs]); for caspofungin, it was 99.6% (11.4% VME, 0.09% ME, and 0.19% miE); and for micafungin, it was 99.6% (14.3% VME, 0.15% ME, and 0.17% miE). There were species-specific differences that led to unacceptably high VME for <i>Candida dubliniensis</i> with all agents and for <i>Candida parapsilosis</i> when caspofungin or micafungin but not anidulafungin was used as the comparator. Genetic analysis showed rezafungin nonsusceptibility correlated well with FKS hotspot mutations. The best-performing surrogate was anidulafungin, which can be used to predict rezafungin susceptible or nonsusceptible in <i>Candida albicans, Candida glabrata, Candida parapsilosis, Candida tropicalis,</i> and <i>Candida krusei</i> with low error rates and ≥90% essential and categorical agreement. Micafungin or caspofungin can also be used as a surrogate marker for predicting rezafungin susceptible or nonsusceptible in <i>C. albicans</i>, <i>C. glabrata</i>, <i>C. tropicalis</i>, and <i>C. krusei</i>. No surrogate performs appropriately to determine rezafungin susceptibility for <i>C. dubliniensis</i>.</p>","PeriodicalId":15511,"journal":{"name":"Journal of Clinical Microbiology","volume":" ","pages":"e0112924"},"PeriodicalIF":6.1,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11837505/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143006387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction for Sulaiman et al., "The Brief Case: A fatal case of Legionella pneumophila in an elderly patient". 更正Sulaiman等人的“简短病例:一例老年患者嗜肺军团菌死亡病例”。
IF 6.1 2区 医学 Q1 MICROBIOLOGY Pub Date : 2025-02-19 Epub Date: 2025-01-08 DOI: 10.1128/jcm.01847-24
Andrew Sulaiman, Emily Gisriel, Karen C Carroll
{"title":"Correction for Sulaiman et al., \"The Brief Case: A fatal case of <i>Legionella pneumophila</i> in an elderly patient\".","authors":"Andrew Sulaiman, Emily Gisriel, Karen C Carroll","doi":"10.1128/jcm.01847-24","DOIUrl":"10.1128/jcm.01847-24","url":null,"abstract":"","PeriodicalId":15511,"journal":{"name":"Journal of Clinical Microbiology","volume":" ","pages":"e0184724"},"PeriodicalIF":6.1,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11837557/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142949681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multicenter evaluation of Fourier transform infrared (FTIR) spectroscopy as a first-line typing tool for carbapenemase-producing Klebsiella pneumoniae in clinical settings. 傅立叶变换红外光谱(FTIR)作为临床环境中产碳青霉烯酶肺炎克雷伯菌一线分型工具的多中心评估。
IF 6.1 2区 医学 Q1 MICROBIOLOGY Pub Date : 2025-01-31 Epub Date: 2024-11-27 DOI: 10.1128/jcm.01122-24
Ana Candela, David Rodríguez-Temporal, Pilar Lumbreras, Paula Guijarro-Sánchez, Manuel J Arroyo, Fernando Vázquez, Alejandro Beceiro, Germán Bou, Patricia Muñoz, Marina Oviaño, Javier Fernández, Belén Rodríguez-Sánchez

Early use of infection control methods is critical for preventing the spread of antimicrobial resistance. Whole-genome sequencing (WGS) is considered the gold standard for investigating outbreaks; however, the turnaround time is usually too long for clinical decision-making and the method is also costly. The aim of this study was to evaluate the performance of Fourier transform infrared (FTIR) and artificial intelligence tools as a first-line typing tool for typing carbapenemase-producing Klebsiella pneumoniae (CPK) in the hospital setting. For this purpose, we analyzed 365 CPK isolates from two tertiary hospitals in Spain in parallel by applying unsupervised principal component analysis (PCA) and supervised algorithms (artificial neural network [ANN], support vector machine [SVM] linear, SVM radial basis function in the IR Biotyper software, and random forest in the Clover MSDAS software). Concordance with FTIR clustering considering the sequence type (ST) and the clonal cluster, obtained by cgMLST for reference purposes, was measured using the adjusted Wallace index (AWI), yielding values of 0.611 and 0.652, respectively. Different regions of the spectra were studied in relation to repeatability and reproducibility, and the polysaccharides region proved the best for FTIR differential analysis. The best results for accuracy were obtained using the ANN algorithm in the IR Biotyper software, with 80.5% of correct prediction. Regarding accuracy, the poorest results were obtained for isolates belonging to ST392 (55.5%) and the best results for ST307 (94.4%). The findings demonstrate the utility of the FTIR method as a rapid, inexpensive, first-line typing tool for detecting CPK, preserving WGS for confirmation and further characterization.

及早使用感染控制方法对于防止抗菌药耐药性的传播至关重要。全基因组测序(WGS)被认为是调查疫情的黄金标准;然而,对于临床决策而言,周转时间通常太长,而且该方法成本高昂。本研究旨在评估傅立叶变换红外光谱(FTIR)和人工智能工具作为一线分型工具在医院环境中对产碳青霉烯酶肺炎克雷伯菌(CPK)进行分型的性能。为此,我们采用无监督主成分分析(PCA)和有监督算法(IR Biotyper 软件中的人工神经网络[ANN]、线性支持向量机[SVM]、SVM 径向基函数,以及 Clover MSDAS 软件中的随机森林)对来自西班牙两家三级医院的 365 株 CPK 分离菌进行了平行分析。使用调整后的华莱士指数(AWI)来衡量傅立叶变换红外光谱聚类与序列类型(ST)和克隆聚类(由 cgMLST 获得,以供参考)的一致性,结果分别为 0.611 和 0.652。对光谱的不同区域进行了重复性和再现性研究,结果表明多糖区域最适合傅立叶变换红外微分分析。使用红外生物分析仪软件中的 ANN 算法获得的准确率最高,预测正确率达 80.5%。在准确性方面,属于 ST392 的分离物的结果最差(55.5%),而 ST307 的结果最好(94.4%)。研究结果表明,傅立叶变换红外光谱法是检测 CPK 的快速、廉价、一线分型工具,可保留 WGS 用于确认和进一步定性。
{"title":"Multicenter evaluation of Fourier transform infrared (FTIR) spectroscopy as a first-line typing tool for carbapenemase-producing <i>Klebsiella pneumoniae</i> in clinical settings.","authors":"Ana Candela, David Rodríguez-Temporal, Pilar Lumbreras, Paula Guijarro-Sánchez, Manuel J Arroyo, Fernando Vázquez, Alejandro Beceiro, Germán Bou, Patricia Muñoz, Marina Oviaño, Javier Fernández, Belén Rodríguez-Sánchez","doi":"10.1128/jcm.01122-24","DOIUrl":"10.1128/jcm.01122-24","url":null,"abstract":"<p><p>Early use of infection control methods is critical for preventing the spread of antimicrobial resistance. Whole-genome sequencing (WGS) is considered the gold standard for investigating outbreaks; however, the turnaround time is usually too long for clinical decision-making and the method is also costly. The aim of this study was to evaluate the performance of Fourier transform infrared (FTIR) and artificial intelligence tools as a first-line typing tool for typing carbapenemase-producing <i>Klebsiella pneumoniae</i> (CPK) in the hospital setting. For this purpose, we analyzed 365 CPK isolates from two tertiary hospitals in Spain in parallel by applying unsupervised principal component analysis (PCA) and supervised algorithms (artificial neural network [ANN], support vector machine [SVM] linear, SVM radial basis function in the IR Biotyper software, and random forest in the Clover MSDAS software). Concordance with FTIR clustering considering the sequence type (ST) and the clonal cluster, obtained by cgMLST for reference purposes, was measured using the adjusted Wallace index (AWI), yielding values of 0.611 and 0.652, respectively. Different regions of the spectra were studied in relation to repeatability and reproducibility, and the polysaccharides region proved the best for FTIR differential analysis. The best results for accuracy were obtained using the ANN algorithm in the IR Biotyper software, with 80.5% of correct prediction. Regarding accuracy, the poorest results were obtained for isolates belonging to ST392 (55.5%) and the best results for ST307 (94.4%). The findings demonstrate the utility of the FTIR method as a rapid, inexpensive, first-line typing tool for detecting CPK, preserving WGS for confirmation and further characterization.</p>","PeriodicalId":15511,"journal":{"name":"Journal of Clinical Microbiology","volume":" ","pages":"e0112224"},"PeriodicalIF":6.1,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11784409/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142729042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emergence of terbinafine-resistant Trichophyton indotineae in Ontario, Canada, 2014-2023. 2014-2023 年加拿大安大略省出现的耐特比萘芬毛癣菌。
IF 6.1 2区 医学 Q1 MICROBIOLOGY Pub Date : 2025-01-31 Epub Date: 2024-11-25 DOI: 10.1128/jcm.01535-24
Lisa R McTaggart, Kirby Cronin, Sonja Ruscica, Samir N Patel, Julianne V Kus
<p><p><i>Trichophyton indotineae</i> is an emerging fungal pathogen capable of causing extensive recalcitrant dermatophytosis exacerbated by frequently retained terbinafine resistance. Cases of dermatophytosis due to <i>T. indotineae</i> have increased dramatically in India in recent years. Other countries have reported imported infection cases, causing public health concerns over the potential global spread of this drug-resistant pathogen. We describe <i>T. indotineae</i> from 47 clinical cases in Ontario, Canada, from 2014 to 2023, based on 50 isolates received by the provincial public health laboratory. Although detected in Ontario as early as 2014, cases increased sharply in 2022-2023. The majority of cases were found in 20 to 64-year-olds (83.0%). Cases from 2022 to 2023 were noted in only 8 of 34 public health units, clustering in large urban centers. Based on genomic epidemiology, Ontario isolates were genetically similar to isolates from other countries. Neither temporal nor geographic clustering based on country or public health unit was observed, suggesting Ontario cases represented recent introductions from endemic regions, although limited local transmission cannot be ruled out. Genome diversity (4.4 × 10<sup>-6</sup>) was extremely low, consistent with the hypothesized recent emergence and clonal population structure of <i>T. indotineae</i>. Most (71.4%) cases were terbinafine-resistant, with isolates exhibiting either the L393F/L393S (<i>n</i> = 3) or F397L (<i>n</i> = 27) squalene epoxidase substitution. Decreased susceptibility to itraconazole or voriconazole was found among 23.7% of isolates and was frequently associated with <i>CYP51B</i> gene duplication. Terbinafine-resistant <i>T. indotineae</i> infections are escalating in Ontario, meriting enhanced laboratory detection methods and public health efforts to increase the awareness of recalcitrant dermatophytoses in order to promptly initiate appropriate treatment and control transmission.IMPORTANCECases of dermatophytosis caused by emerging pathogen <i>Trichophyton indotineae</i> are increasing worldwide. Many are resistant to first-line treatment option terbinafine, resulting in difficult-to-treat cases. We describe the emergence of cases of <i>T. indotineae</i> infections in Ontario, Canada. The incidence in primarily urban centers increased dramatically in 2022-2023, with a large percentage of isolates resistant to terbinafine. Decreased susceptibility to azoles was also observed for some isolates, raising concern over the potential evolution of multi-drug resistance. Ontario <i>T. indotineae</i> isolates were genetically similar to those from disparate locales worldwide, signifying the global nature of this public health concern. Together with other reports, this study serves to raise public health awareness to promote better laboratory detection procedures, prompt appropriate treatment of recalcitrant dermatophytoses, and inform infection prevention and control measures.<
indotineae 毛癣菌是一种新出现的真菌病原体,能够引起广泛的顽固性皮肤癣菌病,并因经常保留特比萘芬抗药性而恶化。近年来,印度由 T. indotineae 引起的皮癣病病例急剧增加。其他国家也报告了输入性感染病例,引起了公众对这种耐药病原体可能在全球传播的担忧。我们根据省公共卫生实验室收到的 50 份分离物,描述了 2014 年至 2023 年加拿大安大略省 47 例临床病例中的 T. indotineae。虽然安大略省早在 2014 年就发现了这种病原体,但在 2022-2023 年病例急剧增加。大多数病例出现在 20 至 64 岁的人群中(83.0%)。2022 年至 2023 年期间,34 个公共卫生单位中只有 8 个发现病例,病例主要集中在大城市中心。根据基因组流行病学,安大略省的分离株在基因上与其他国家的分离株相似。没有观察到基于国家或公共卫生单位的时间或地理集群,这表明安大略省的病例是最近从流行地区引入的,尽管不能排除有限的本地传播。基因组多样性(4.4 × 10-6)极低,与假设的 T. indotineae 最近出现和克隆种群结构一致。大多数病例(71.4%)对特比萘芬耐药,分离株表现出 L393F/L393S (n = 3)或 F397L (n = 27)角鲨烯环氧化物酶置换。23.7%的分离株对伊曲康唑或伏立康唑的敏感性降低,这通常与 CYP51B 基因重复有关。在安大略省,对特比萘芬耐药的毛癣菌感染正在不断增加,因此需要加强实验室检测方法和公共卫生工作,提高人们对顽固性皮肤癣菌病的认识,以便及时启动适当的治疗和控制传播。许多病例对一线治疗方案特比萘芬产生抗药性,导致治疗困难。我们描述了加拿大安大略省出现的毛癣菌感染病例。2022-2023 年,主要城市中心的发病率急剧上升,其中很大一部分分离株对特比萘芬产生耐药性。一些分离株对唑类药物的敏感性也有所下降,这引起了人们对多种药物耐药性潜在演变的担忧。安大略省的 T. indotineae 分离物与世界各地的分离物在基因上相似,这表明这一公共卫生问题具有全球性。这项研究与其他报告一起,有助于提高公众的健康意识,促进更好的实验室检测程序,及时对顽固性皮肤癣菌病进行适当治疗,并为感染预防和控制措施提供信息。
{"title":"Emergence of terbinafine-resistant <i>Trichophyton indotineae</i> in Ontario, Canada, 2014-2023.","authors":"Lisa R McTaggart, Kirby Cronin, Sonja Ruscica, Samir N Patel, Julianne V Kus","doi":"10.1128/jcm.01535-24","DOIUrl":"10.1128/jcm.01535-24","url":null,"abstract":"&lt;p&gt;&lt;p&gt;&lt;i&gt;Trichophyton indotineae&lt;/i&gt; is an emerging fungal pathogen capable of causing extensive recalcitrant dermatophytosis exacerbated by frequently retained terbinafine resistance. Cases of dermatophytosis due to &lt;i&gt;T. indotineae&lt;/i&gt; have increased dramatically in India in recent years. Other countries have reported imported infection cases, causing public health concerns over the potential global spread of this drug-resistant pathogen. We describe &lt;i&gt;T. indotineae&lt;/i&gt; from 47 clinical cases in Ontario, Canada, from 2014 to 2023, based on 50 isolates received by the provincial public health laboratory. Although detected in Ontario as early as 2014, cases increased sharply in 2022-2023. The majority of cases were found in 20 to 64-year-olds (83.0%). Cases from 2022 to 2023 were noted in only 8 of 34 public health units, clustering in large urban centers. Based on genomic epidemiology, Ontario isolates were genetically similar to isolates from other countries. Neither temporal nor geographic clustering based on country or public health unit was observed, suggesting Ontario cases represented recent introductions from endemic regions, although limited local transmission cannot be ruled out. Genome diversity (4.4 × 10&lt;sup&gt;-6&lt;/sup&gt;) was extremely low, consistent with the hypothesized recent emergence and clonal population structure of &lt;i&gt;T. indotineae&lt;/i&gt;. Most (71.4%) cases were terbinafine-resistant, with isolates exhibiting either the L393F/L393S (&lt;i&gt;n&lt;/i&gt; = 3) or F397L (&lt;i&gt;n&lt;/i&gt; = 27) squalene epoxidase substitution. Decreased susceptibility to itraconazole or voriconazole was found among 23.7% of isolates and was frequently associated with &lt;i&gt;CYP51B&lt;/i&gt; gene duplication. Terbinafine-resistant &lt;i&gt;T. indotineae&lt;/i&gt; infections are escalating in Ontario, meriting enhanced laboratory detection methods and public health efforts to increase the awareness of recalcitrant dermatophytoses in order to promptly initiate appropriate treatment and control transmission.IMPORTANCECases of dermatophytosis caused by emerging pathogen &lt;i&gt;Trichophyton indotineae&lt;/i&gt; are increasing worldwide. Many are resistant to first-line treatment option terbinafine, resulting in difficult-to-treat cases. We describe the emergence of cases of &lt;i&gt;T. indotineae&lt;/i&gt; infections in Ontario, Canada. The incidence in primarily urban centers increased dramatically in 2022-2023, with a large percentage of isolates resistant to terbinafine. Decreased susceptibility to azoles was also observed for some isolates, raising concern over the potential evolution of multi-drug resistance. Ontario &lt;i&gt;T. indotineae&lt;/i&gt; isolates were genetically similar to those from disparate locales worldwide, signifying the global nature of this public health concern. Together with other reports, this study serves to raise public health awareness to promote better laboratory detection procedures, prompt appropriate treatment of recalcitrant dermatophytoses, and inform infection prevention and control measures.&lt;","PeriodicalId":15511,"journal":{"name":"Journal of Clinical Microbiology","volume":" ","pages":"e0153524"},"PeriodicalIF":6.1,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11784349/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142710176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Yield of solid AFB culture in addition to automated liquid culture for diagnosis of mycobacterial infections. 在诊断分枝杆菌感染时,除自动液体培养外,固体 AFB 培养的产量。
IF 6.1 2区 医学 Q1 MICROBIOLOGY Pub Date : 2025-01-31 Epub Date: 2024-11-27 DOI: 10.1128/jcm.01551-24
Dongsheng Han, Niaz Banaei
{"title":"Yield of solid AFB culture in addition to automated liquid culture for diagnosis of mycobacterial infections.","authors":"Dongsheng Han, Niaz Banaei","doi":"10.1128/jcm.01551-24","DOIUrl":"10.1128/jcm.01551-24","url":null,"abstract":"","PeriodicalId":15511,"journal":{"name":"Journal of Clinical Microbiology","volume":" ","pages":"e0155124"},"PeriodicalIF":6.1,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11784161/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142729045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Photo Quiz: A 22-year-old leukemic patient with diarrhea.
IF 6.1 2区 医学 Q1 MICROBIOLOGY Pub Date : 2025-01-31 DOI: 10.1128/jcm.00312-24
Debasish Biswal, Bijay Ranjan Mirdha
{"title":"Photo Quiz: A 22-year-old leukemic patient with diarrhea.","authors":"Debasish Biswal, Bijay Ranjan Mirdha","doi":"10.1128/jcm.00312-24","DOIUrl":"10.1128/jcm.00312-24","url":null,"abstract":"","PeriodicalId":15511,"journal":{"name":"Journal of Clinical Microbiology","volume":"63 1","pages":"e0031224"},"PeriodicalIF":6.1,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11784109/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143065906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeted syndromic next-generation sequencing panel for simultaneous detection of pathogens associated with bovine reproductive failure. 用于同时检测与牛繁殖衰竭相关的病原体的靶向综合征下一代测序面板。
IF 6.1 2区 医学 Q1 MICROBIOLOGY Pub Date : 2025-01-31 Epub Date: 2024-12-10 DOI: 10.1128/jcm.01433-24
Dhinesh Periyasamy, Yanyun Huang, Janet E Hill

Bovine reproductive failure, which includes infertility, abortion, and stillbirth in cattle, leads to significant economic losses for beef and milk producers. Diagnosing the infectious causes of bovine reproductive failure is challenging as there are multiple pathogens associated with it. The traditional stepwise approach to diagnostic testing is time-consuming and can cause significant delays. In this study, we have developed a syndromic next-generation sequencing panel (BovReproSeq) for the simultaneous detection of 17 pathogens (bacteria, virus, and protozoa) associated with bovine reproductive failure. This targeted approach involves amplifying multiple pathogen-specific targets using ultra-multiplex PCR, followed by sequencing with the Oxford Nanopore platform and subsequent analysis of the data using a custom bioinformatic pipeline to determine the presence or absence of pathogens. We tested 116 clinical samples and found that BovReproSeq results matched with current diagnostic methods for 93% of the samples, and most of the disagreements occurring in samples with very low pathogen loads (Ct >35). At the optimal read-count threshold of 10 reads (minimum number of reads to classify the sample as positive), the clinical sensitivity of the assay was approximately 82%, while clinical specificity was 100%. The overall accuracy of the assay was 98.8%. Matthews correlation coefficient (correlation coefficient of binary classification) was approximately 0.90 and F1 score (harmonic mean of precision and recall) was 0.90, indicating excellent overall performance. Our study presents a significant advancement in detecting the infectious agents associated with bovine reproductive failure and the BovReproSeq panel's ability to detect 17 pathogens makes it a promising tool for veterinary diagnostics.IMPORTANCEBovine reproductive failure causes substantial economic losses to beef and milk producers, and infectious disease contributes significantly to this syndrome. Etiologic diagnosis is complicated since multiple pathogens can be involved and infections with some pathogens are asymptomatic or cause similar clinical signs. A stepwise approach to diagnostic testing is time-consuming and increases the risk of missing the correct diagnosis. BovReproSeq is a next-generation sequencing-based diagnostic panel that allows detection of 17 reproductive failure pathogens simultaneously.

牛的生殖功能衰竭,包括牛的不孕、流产和死胎,给牛肉和牛奶生产商带来了重大的经济损失。诊断牛生殖衰竭的感染原因具有挑战性,因为有多种病原体与之相关。传统的逐步诊断测试方法非常耗时,并可能导致严重的延误。在这项研究中,我们开发了一个综合征下一代测序小组(bovreseq),用于同时检测与牛繁殖失败相关的17种病原体(细菌,病毒和原生动物)。这种靶向方法包括使用超多重PCR扩增多个病原体特异性靶点,然后使用牛津纳米孔平台进行测序,然后使用定制的生物信息学管道对数据进行分析,以确定病原体的存在或不存在。我们测试了116个临床样本,发现bovreseq结果与93%的样本的当前诊断方法相匹配,并且大多数不一致发生在病原体载量非常低的样本中(Ct bbb35)。在最佳读取计数阈值为10个读取(将样本分类为阳性的最小读取数)时,该检测的临床敏感性约为82%,而临床特异性为100%。该方法的总体准确度为98.8%。马修斯相关系数(二分类相关系数)约为0.90,F1分数(查准率和查全率的调和平均值)为0.90,整体表现优异。我们的研究在检测与牛繁殖失败相关的感染因子方面取得了重大进展,bovreseq小组检测17种病原体的能力使其成为兽医诊断的一个有前途的工具。牛的繁殖失败给牛肉和牛奶生产者造成了巨大的经济损失,传染病是造成这一综合症的重要原因。病因诊断是复杂的,因为可能涉及多种病原体,一些病原体感染是无症状的或引起类似的临床症状。逐步进行诊断测试既耗时又增加了错过正确诊断的风险。bovreseq是下一代基于测序的诊断面板,可同时检测17种生殖失败病原体。
{"title":"Targeted syndromic next-generation sequencing panel for simultaneous detection of pathogens associated with bovine reproductive failure.","authors":"Dhinesh Periyasamy, Yanyun Huang, Janet E Hill","doi":"10.1128/jcm.01433-24","DOIUrl":"10.1128/jcm.01433-24","url":null,"abstract":"<p><p>Bovine reproductive failure, which includes infertility, abortion, and stillbirth in cattle, leads to significant economic losses for beef and milk producers. Diagnosing the infectious causes of bovine reproductive failure is challenging as there are multiple pathogens associated with it. The traditional stepwise approach to diagnostic testing is time-consuming and can cause significant delays. In this study, we have developed a syndromic next-generation sequencing panel (BovReproSeq) for the simultaneous detection of 17 pathogens (bacteria, virus, and protozoa) associated with bovine reproductive failure. This targeted approach involves amplifying multiple pathogen-specific targets using ultra-multiplex PCR, followed by sequencing with the Oxford Nanopore platform and subsequent analysis of the data using a custom bioinformatic pipeline to determine the presence or absence of pathogens. We tested 116 clinical samples and found that BovReproSeq results matched with current diagnostic methods for 93% of the samples, and most of the disagreements occurring in samples with very low pathogen loads (Ct >35). At the optimal read-count threshold of 10 reads (minimum number of reads to classify the sample as positive), the clinical sensitivity of the assay was approximately 82%, while clinical specificity was 100%. The overall accuracy of the assay was 98.8%. Matthews correlation coefficient (correlation coefficient of binary classification) was approximately 0.90 and F1 score (harmonic mean of precision and recall) was 0.90, indicating excellent overall performance. Our study presents a significant advancement in detecting the infectious agents associated with bovine reproductive failure and the BovReproSeq panel's ability to detect 17 pathogens makes it a promising tool for veterinary diagnostics.IMPORTANCEBovine reproductive failure causes substantial economic losses to beef and milk producers, and infectious disease contributes significantly to this syndrome. Etiologic diagnosis is complicated since multiple pathogens can be involved and infections with some pathogens are asymptomatic or cause similar clinical signs. A stepwise approach to diagnostic testing is time-consuming and increases the risk of missing the correct diagnosis. BovReproSeq is a next-generation sequencing-based diagnostic panel that allows detection of 17 reproductive failure pathogens simultaneously.</p>","PeriodicalId":15511,"journal":{"name":"Journal of Clinical Microbiology","volume":" ","pages":"e0143324"},"PeriodicalIF":6.1,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11784112/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Microbiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1